Summary & Key Points
"From May 11 to 13, 2026, the PAC-CI Program offices hosted ๐ฅ'๐๐ญ๐๐ฅ๐ข๐๐ซ ๐๐ ๐๐จ-๐๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ข๐จ๐ง ๐๐ ๐ฅ๐ ๐ฌ๐ญ๐ซ๐๐ญ๐ฬ๐ ๐ข๐ ๐๐ญ ๐๐๐ฌ ๐จ๐ฎ๐ญ๐ข๐ฅ๐ฌ ๐๐ ๐ฅ๐ ๐๐ก๐ข๐ฆ๐ข๐จ๐ฉ๐ซ๐ฬ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง ๐๐ฎ ๐๐๐ฅ๐ฎ๐๐ข๐ฌ๐ฆ๐ ๐๐ฬ๐ซ๐๐ง"
๐๐ ๐๐ซ๐จ๐ ๐ซ๐๐ฆ๐ฆ๐ ๐๐๐-๐๐ ๐๐๐๐ฎ๐๐ข๐ฅ๐ฅ๐ ๐ฅโ๐๐ญ๐๐ฅ๐ข๐๐ซ ๐๐ ๐๐จ-๐๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ข๐จ๐ง ๐๐ฎ ๐ฉ๐ซ๐จ๐ฃ๐๐ญ ๐๐๐๐๐๐๐-๐๐๐
From May 11 to 13, 2026, the PAC-CI Program offices hosted ๐ฅ'๐๐ญ๐๐ฅ๐ข๐๐ซ ๐๐ ๐๐จ-๐๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ข๐จ๐ง ๐๐ ๐ฅ๐ ๐ฌ๐ญ๐ซ๐๐ญ๐ฬ๐ ๐ข๐ ๐๐ญ ๐๐๐ฌ ๐จ๐ฎ๐ญ๐ข๐ฅ๐ฌ ๐๐ ๐ฅ๐ ๐๐ก๐ข๐ฆ๐ข๐จ๐ฉ๐ซ๐ฬ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง ๐๐ฎ ๐๐๐ฅ๐ฎ๐๐ข๐ฌ๐ฆ๐ ๐๐ฬ๐ซ๐๐ง๐ง๐ ๐ฬ ๐๐๐ฌ๐ ๐๐จ๐ฆ๐ฆ๐ฎ๐ง๐๐ฎ๐ญ๐๐ข๐ซ๐ (๐-๐๐๐), organized as part of the COMBINE-PMC project.
This workshop brought together several key stakeholders in the fight against malaria in Cรดte d'Ivoire: ๐ฅ๐ ๐๐ซ๐จ๐ ๐ซ๐๐ฆ๐ฆ๐ ๐๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐ ๐๐ฎ๐ญ๐ญ๐ ๐๐จ๐ง๐ญ๐ซ๐ ๐ฅ๐ ๐๐๐ฅ๐ฎ๐๐ข๐ฌ๐ฆ๐ (๐๐๐๐), ๐ฅ๐ ๐๐ข๐ซ๐๐๐ญ๐ข๐จ๐ง ๐๐ฬ๐ ๐ข๐จ๐ง๐๐ฅ๐ ๐๐ ๐ฅ๐ ๐๐๐ง๐ญ๐ฬ ๐๐ ๐ฅ๐ ๐๐๐ซ๐๐ก๐จ๐ฎ๐ฬ, ๐ฅ๐ ๐๐ข๐ซ๐๐๐ญ๐ข๐จ๐ง ๐๐ฬ๐ฉ๐๐ซ๐ญ๐๐ฆ๐๐ง๐ญ๐๐ฅ๐ ๐๐ ๐ฅ๐ ๐๐๐ง๐ญ๐ฬ ๐๐ ๐๐จ๐ฎ๐๐๐ฅ๐ฬ, ๐ฅ'๐๐ฎ๐ญ๐จ๐ซ๐ข๐ญ๐ฬ ๐๐ฏ๐จ๐ข๐ซ๐ข๐๐ง๐ง๐ ๐๐ ๐๐ฬ๐ ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐ช๐ฎ๐ (๐๐๐๐), ๐๐ข๐ง๐ฌ๐ข ๐ช๐ฎ๐ ๐๐๐ฌ ๐จ๐ซ๐ ๐๐ง๐ข๐ฌ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ง๐จ๐ง ๐ ๐จ๐ฎ๐ฏ๐๐ซ๐ง๐๐ฆ๐๐ง๐ญ๐๐ฅ๐๐ฌ ๐๐ญ ๐๐๐ฌ ๐๐ก๐๐ซ๐๐ก๐๐ฎ๐ซ๐ฌ ๐ง๐๐ญ๐ข๐จ๐ง๐๐ฎ๐ฑ ๐๐ญ ๐ข๐ง๐ญ๐๐ซ๐ง๐๐ญ๐ข๐จ๐ง๐๐ฎ๐ฑ.
Funded by Expertise France, the COMBINE-PMC project is based on an interdisciplinary consortium bringing together the National Malaria Control Programs (PNLP) of Cรดte d'Ivoire and Togo, the PAC-CI Program, CARESP-Togo, the IRD (France), and the University of Bordeaux.ย
It aims to evaluate ๐ฎ๐ง๐ ๐ฌ๐ญ๐ซ๐๐ญ๐ฬ๐ ๐ข๐ ๐ข๐ง๐ง๐จ๐ฏ๐๐ง๐ญ๐ ๐๐ ๐๐ข๐ฌ๐ฉ๐๐ง๐ฌ๐๐ญ๐ข๐จ๐ง ๐๐จ๐ฆ๐ฆ๐ฎ๐ง๐๐ฎ๐ญ๐๐ข๐ซ๐ ๐๐ ๐ฅ๐ ๐๐ฎ๐ฅ๐๐๐๐จ๐ฑ๐ข๐ง๐-๐๐ฒ๐ซ๐ข๐ฆ๐ฬ๐ญ๐ก๐๐ฆ๐ข๐ง๐ (๐๐) ๐ฉ๐๐ซ ๐ฅ๐๐ฌ ๐๐ ๐๐ง๐ญ๐ฌ ๐๐ ๐๐๐ง๐ญ๐ฬ ๐๐จ๐ฆ๐ฆ๐ฎ๐ง๐๐ฎ๐ญ๐๐ข๐ซ๐๐ฌ, in order toimprove malaria prevention and vaccination coverage among children under two years of age.
The workshop was attended by ๐ฅ'๐ข๐ง๐ฏ๐๐ฌ๐ญ๐ข๐ ๐๐ญ๐ซ๐ข๐๐ ๐ฉ๐ซ๐ข๐ง๐๐ข๐ฉ๐๐ฅ๐ (๐๐) ๐๐ฎ ๐ฉ๐ซ๐จ๐ฃ๐๐ญ, the Dr. Shino Arikawa, and has benefited from the active participation of partner scientific and technical teams. In Cรดte d'Ivoire, the project is coordinated by Dr. SERI Benjamim, supported by the PAC-CI team, which is fully committed to scientific and methodological coordination.
Over the course of three days, participants engaged in collaborative discussions on several strategic themes: the operational implementation model, SP procurement, community mobilization, pharmacovigilance, human resources management, monitoring and evaluation, and data reporting mechanisms.
These discussions led to the development of a community-based SP distribution strategy tailored to the Ivorian context, accompanied by operational tools and an implementation timeline validated by all stakeholders.
In Cรดte dโIvoire, the project will be rolled out in the Bouaflรฉ health district, which is subdivided into three zones: an intervention zone, where the C-CPP will be implemented; a control zone, where SP will be administered according to the standard strategy; and a buffer zone, intended to limit migration flows between the first two zones. Implementation will begin in October 2026.
Through this initiative, the PAC-CI Program reaffirms its commitment, alongside health authorities and its partners, to innovative solutions tailored to community realities in the fight against malaria in Africa.
Christian KOUADIO
Associate researcher at PAC-CI, contributing to the advancement of scientific research and public health in Cรดte d'Ivoire.
Contact the author